Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support research on the efficacy of covid-19 vaccines for people with low immunity.
Public Health England are leading the surveillance strategy for the COVID-19 vaccination programme, which will continue to monitor how effective each vaccine is at protecting against a range of outcomes including infection, symptomatic disease, hospitalisations, mortality and onwards transmission. The strategy includes further research on how effectiveness varies by subgroup, including different clinical risk groups. Evidence on these outcomes will be generated through routine data sources, including routine testing data and general practitioner electronic health records, as well as through enhanced surveillance and building upon established research studies in specific populations.